Insulet Corp (PODD) has emerged as a top pick among hedge funds in the medical device sector, buoyed by overwhelmingly bullish analyst ratings and a price target suggesting significant growth potential. The company's innovative tubeless insulin pump system is seen as a key driver.
Analyst Matthew O'Brien reaffirms an Overweight rating and $420 price target for Stryker, highlighting the potential of its new Mako RPS handheld orthopedic robot to capture cost-sensitive markets and compete with rivals like Zimmer Biomet.
Boston Scientific (BSX) is attracting bullish analyst attention after its strategic acquisition of Penumbra, with Truist Securities reiterating a Buy rating and a $120 price target, citing enhanced business durability and growth prospects.
DexCom Inc. (DXCM) has released preliminary Q4 figures that exceeded expectations and provided robust long-term guidance, reinforcing its position as a favored pick among analysts and hedge funds in the medical devices sector.
Despite near-term headwinds in its Nutrition segment, Abbott Laboratories (ABT) maintains a bullish long-term outlook with solid organic sales growth projected for 2026, even as major analysts adjust their price targets following Q4 results.
Wall Street analysts are raising price targets on Edwards Lifesciences, citing a renewed growth cycle driven by TAVR expansion and a strong product pipeline, positioning the medical device maker as a favored pick.
A recent physician survey on renal denervation procedure volumes has prompted analysts to adopt a more measured view of Medtronic's near-term growth potential, even as the medical device giant remains a favored long-term holding.
Driven by falling costs and strong incentives, heavy manufacturing is increasingly turning to on-site solar power. This shift is transforming large factory roofs from passive structures into strategic assets for cutting energy bills and emissions.
The world's largest payment networks are taking a measured approach to stablecoins for everyday consumer transactions, citing a lack of clear demand in developed markets and emphasizing their role as infrastructure providers rather than disruptors.
The global professional services giant reported stronger-than-expected fourth-quarter results, with revenue climbing 8.7% to $6.60 billion. Strategic investments in digital infrastructure and artificial intelligence are credited for driving growth despite headwinds in insurance pricing.
Usama Ghanem, an Egyptian student at King's College London, faces imminent deportation after disciplinary action linked to his pro-Palestinian activism. He claims the university's response mirrors the political persecution he fled in Egypt, raising urgent questions about academic freedom and the treatment of international dissent.
Novo Nordisk charts a bold new course, launching a pivotal oral obesity drug while restructuring its workforce and deepening its investment in next-generation cell therapies for metabolic diseases.
After a staggering multi-year rally, shares of American Superconductor (AMSC) are showing signs of cooling momentum. With a sky-high P/E ratio and a significant gap between its current price and analyst fair value estimates, investors are grappling with a critical question: is this a buying opportunity or a signal to take profits?
Sanofi announces promising late-stage results for its immunology candidate amlitelimab and expands into genetic therapies via an investment in Sensorion, signaling a strategic push into high-value therapeutic areas.
Gold and silver prices experienced a dramatic sell-off following President Trump's surprise nomination of former Fed governor Kevin Warsh to chair the Federal Reserve, sparking intense debate over future monetary policy direction.
The restaurant chain Steak 'n Shake has announced it will contribute $1,000 to tax-advantaged investment accounts for employees' newborns, aligning with a growing corporate trend to supplement the federal 'Trump Accounts' program aimed at generational wealth building.
The arrest of former CNN anchor Don Lemon following his coverage of immigration protests has ignited a fierce debate over press freedoms and federal overreach, as a Justice Department civil rights investigation into the fatal shooting of a local nurse adds fuel to the political fire.
While Q3 earnings reflect challenging market conditions, the chemical giant reports strong North American performance and accelerates its strategic shift, breaking ground on a flagship advanced recycling plant in Germany and planning a larger facility in Houston.
President Trump nominates Kevin Warsh, a former Fed governor with Wall Street ties, to succeed Jerome Powell as Federal Reserve Chair. His confirmation faces scrutiny amid questions over monetary policy direction and the central bank's political independence.
Despite a major new Bitcoin purchase, MicroStrategy's stock has plunged to its lowest level since September 2024, as market turbulence and mixed analyst sentiment pressure the crypto-focused software firm ahead of its earnings report.
